Abstract
Introduction, Results and Discussion
Cathepsin D (cath-D) is a ubiquitous lysosomal aspartic protease extensively reported as being an active player in breast cancer ( , ). More recently, cath-D 1 2 has also been discovered as a key mediator of apoptosis induced by many apoptotic agents such as IFN-, Fas/APO, TNF-( ), oxidative stress ( -), adriamycin 3 4 8 and etoposide ( , ), as well as staurosporine ( ). The role of cath-D in apoptosis has been linked to the lysosomal release of mature 34 kDa cath-D into the 9 10 11 cytosol leading in turn to the mitochondrial release of cytochrome c (cyt c) into the cytosol ( -, , ), activation of pro-caspases ( , -), cleavage 4 7 11 12 5 11 13 in vitro of Bid at pH 6.2 ( ), or Bax activation independently of Bid cleavage ( ). Numerous studies have shown that pepstatin A, an aspartic protease inhibitor, could 13 14 partially delay apoptosis induced by IFN-and Fas/APO ( ), staurosporine ( , , ), TNF-( , , ), serum deprivation ( ), oxidative stress ( -) or even 3 11 14 15 3 13 16 17 5 8 when cath-D was micro-injected ( ). These authors have thus concluded that cath-D plays a key role in apoptosis mediated its catalytic activity. However, 12 via cath-D is one of the lysosomal enzymes which requires a more acidic pH to be proteolytically active, relative to the cysteine lysosomal enzymes such as cath-B and -L. Acidification of the cytosol down to pH values of about 6.7-7 is a well-documented phenomenon in apoptosis ( ).
cath-D can cleave its 18 In vitro substrates up to a pH of 5.8, but not above ( ). Hence, it is predictable that the proteolytic activity of cytosolic cath-D would be drastically impaired under 19 adverse pH conditions unfavourable for its catalytic function. It is therefore open to question whether cath-D might be able to cleave cytosolic substrate(s) implicated in the apoptotic cascade. In accordance with this proposal, it was recently described that pepstatin A did not prevent the death of cells treated by etoposide, doxorubicin, anti-CD95 or TNF-( , , ). Furthermore, pepstatin A did not suppress Bid cleavage or pro-caspases-9 and -3 activation by 10 16 20 photodynamic therapy in murine hepatoma cells ( ). Finally, deficiency in cath-D activity did not alter cell death induction in CONCL fibroblasts ( ). 21 20 In the present work, we investigated the role of wild-type cath-D and its proteolytically-inactive counterpart over-expressed by cancer cells in chemotherapeutic-induced cytotoxicity and apoptosis, and more precisely the relevance of cath-D catalytic function. We used the 3Y1-Ad12 cancer cell line - Figure 4A results indicate that cath-D over-expressed by cancer cells contributes to mitochondrial cyt c release in etoposide-treated cells independently of its catalytic function. We then investigated whether cath-D plays a role in the activation of caspases-9 and -3 since these caspases have been shown to play a pivotal role in etoposide-induced apoptosis ( ). ). In parallel experiments, we verified that Z-VAD-FMK efficiently inhibited caspase-3 Figure 5A activation in our cells ( ). Overall, our study has demonstrated that the over-expression of both wild-type and cath-D by cancer cells can enhance the Figure 5B D231 cytotoxicity of chemotherapeutic agents and their apoptotic response to etoposide treatment. Both active and inactive cath-D are rapidly released into the cytosol after etoposide treatment and this phenomenon is closely associated with cyt c release and caspase-dependent apoptotic events. In conclusion, our work ( ) 23 implicates a role for cath-D independent of its catalytic function both in chemotherapeutic-induced cytotoxicity and in etoposide-induced apoptosis, and we suggest that an adequate strategy to identify cytosolic cath-D interacting protein(s) might be the two-yeast hybrid approach.
Figure 1
The over-expression of both catalytically-active and -inactive cath-D by 3Y1-Adl2 cancer cells enhances etoposide-induced cytotoxicity Cells were treated or not with increasing concentrations of etoposide and survival was evaluated by MTT. *, p<0.0005 control cells (Student's -test). versus t
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Figure 3
Catalytically-active and -inactive cath-D are released early in etoposide-induced apoptosis Cells were either exposed to 10 M etoposide for 24 h or left untreated . Cells were incubated first with (A) Immunofluorescence of cath-D. (b, c, e, f) (a, d) anti-human cath-D M1G8 mouse monoclonal antibody followed by a RITC-conjugated goat anti-mouse antibody. (bottom panel) extracted using 20 g/ml and 45 g/ml digitonin for cath-D and cath-D cells, respectively, for 10 min as previously described ( ). Cath-D immunoblotting was D231N 11 performed using an anti-human cath-D monoclonal mouse antibody followed by an anti-mouse peroxidase-conjugated antibody.

Figure 4
Catalytically-active and -inactive cath-D induce mitochondrial release of cyt c and activation of caspases-9 and -3 was analyzed by immunofluorescence using an anti-rat cyt c mouse monoclonal antibody followed by a RITC-conjugated goat anti-mouse antibody. (A) Cyt c Bars, 16 m. was analyzed by immunofluorescence using an anti-rat cleaved caspase-9 rabbit polyclonal antibody or an anti-rat cleaved (B) Activation of caspase-9 and -3 caspase-3 rabbit polyclonal antibody followed by a TexasRed-conjugated or FITC-conjugated goat anti-rabbit antibody. 
